Cold sore lesion microenvironment

The cold sore lesion microenvironment is the localized physiological and pathological site where Herpes Simplex Virus type 1 (HSV-1) undergoes lytic replication following reactivation from latency in the trigeminal ganglia [1]. This environment is defined by a high concentration of viral particles, infected keratinocytes, and a robust recruitment of inflammatory cells such as CD8+ T-cells and macrophages [2]. The progression of the lesion—from prodrome to vesicle formation and crusting—is driven by viral-induced cytolysis and the host's innate and adaptive immune responses [3]. Pharmacological management within this microenvironment typically involves nucleoside analogs that inhibit viral DNA polymerase or surfactants that interfere with viral envelope fusion [4]. As a complex milieu of cellular and viral components, it is not a single molecular target but rather a therapeutic site where multiple pathways are addressed to reduce viral shedding and accelerate tissue repair [5]. Understanding the dynamics of this microenvironment is essential for optimizing topical and systemic delivery of antiviral agents [1].

Other names

Herpes labialis lesion siteFever blister microenvironmentHSV-1 lytic microenvironmentOral herpes lesion

Inhibition of viral DNA polymerase by nucleoside analogs; prevention of viral-host cell membrane fusion; modulation of the local inflammatory cascade to reduce tissue damage.